Gilead Sciences, Inc (NASDAQ: GILD) open the trading on Wednesday, with great promise as it jumped 1.66% to $121.34, before settling in for the price of $119.36 at the close. Taking a more long-term approach, GILD posted a 52-week range of $88.57-$128.70.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -38.13%. Meanwhile, its Annual Earning per share during the time was -38.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.82%. This publicly-traded company’s shares outstanding now amounts to $1.24 billion, simultaneously with a float of $1.24 billion. The organization now has a market capitalization sitting at $150.54 billion. At the time of writing, stock’s 50-day Moving Average stood at $121.16, while the 200-day Moving Average is $113.10.
Gilead Sciences, Inc (GILD) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Gilead Sciences, Inc’s current insider ownership accounts for 0.21%, in contrast to 88.33% institutional ownership. According to the most recent insider trade that took place on Nov 28 ’25, this organization’s Director sold 5,000 shares at the rate of 125.08, making the entire transaction reach 625,400 in total value, affecting insider ownership by 8,920. Preceding that transaction, on Nov 26 ’25, Company’s Director sold 2,806 for 127.11, making the whole transaction’s value amount to 356,671. This particular insider is now the holder of 1,339 in total.
Gilead Sciences, Inc (GILD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.05 per share during the current fiscal year. Gilead Sciences, Inc’s EPS increase for this current 12-month fiscal period is 76.82% and is forecasted to reach 8.71 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 26.25% through the next 5 years, which can be compared against the -38.13% growth it accomplished over the previous five years trading on the market.
In the same vein, GILD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.46, a figure that is expected to reach 1.87 in the next quarter, and analysts are predicting that it will be 8.71 at the market close of one year from today.
Technical Analysis of Gilead Sciences, Inc (GILD)
[Gilead Sciences, Inc, GILD] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 14.18% While, its Average True Range was 42.67.
Raw Stochastic average of Gilead Sciences, Inc (GILD) in the period of the previous 100 days is set at 64.34%, which indicates a major rise in contrast to 25.84% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.63 that was lower than 2.76 volatility it exhibited in the past 100-days period.
